Amyris, Inc. (AMRS), a leader in the development of sustainable ingredients through synthetic biotechnology, announced the acquisition of OLIKA Inc.
Amyris Inc (NASDAQ:AMRS) announced that it has entered into a product development and production agreement for Vitamin A with Koninklijke DSM N.V.
Amyris Inc (NASDAQ:AMRS) announced agreements for $50 million in equity financing as part of the second tranche of its previously announced financing. The …
Amyris Inc (NASDAQ:AMRS) and the Government of Queensland, Australia announced the next step their plans to develop a leading industrial biotechnology hub in …
Amyris, Inc. (NASDAQ:AMRS) announced that it expects revenue related to its Vitamin E partnership with Nenter to more than double based on the …
Amyris Inc (NASDAQ:AMRS) announced that its partner’s success in developing high performance liquid farnesene rubber (LFR) for use in winter tire applications has …
Amyris Inc (NASDAQ:AMRS) announced that it has successfully expanded its world-class expertise in strain engineering and optimization to 26 key metabolic precursors across …
Amyris Inc (NASDAQ:AMRS) announced that it has expanded the scope of its relationship with Phyto Tech Corp. Blue California is based in Southern …
Amyris, Inc. (NASDAQ:AMRS), the industrial bioscience company, achieved record first-quarter product sales for its Biossance brand, which is delivering high-growth and is expected …
Amyris Inc (NASDAQ:AMRS) announced the Cray Valley’s launch of new tackifying resins produced with the company’s biologically derived Biofene® branded farnesene. The disruptive nature …
